Hopital de L'Enfant-Jesus, CHU de Quebec-Universite Laval

Québec G1J 1Z4

0 studies enrolling now · 1 studies all time

What they study most

Amyotrophic Lateral Sclerosis

Studies at this site

• Evaluation of MN-166 (Ibudilast) for 12 Months Followed by an Open-label Extension for 6 Months in Patients With ALS — Running, not enrolling